Statistics for Avita Medical (id:5368 RCEL)

Valuation metrics

Market cap

313.30M

Enterprise value

314.52M

Trailing P/E (ttm)

-9.32

Forward P/E

-14.57

PEG ratio

-14.57

Price/Sales (ttm)

5.22

Price/Book (mrq)

25.64

Enterprise Value/Revenue

5.24

Enterprise Value/EBITDA

-5.43

Overview

Shares outstanding

26.22M

Float

25.67M

Shares short

1.19M

% Held by insiders

0.01%

% Held by institutions

0.23%

Average volume (10 days)

144.65K

Average volume (90 days)

Price summary

52-Week low

7.51

52-Week high

18.93

52-Week change

19.54%

Beta

1.54

50-Day moving average

10.72

200-Day moving average

11.17

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 30th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-95.47%

Operating margin

-70.63%

Operational effectiveness

Return on assets

-45.37%

Return on equity

-152.44%

Income statement

Revenue (ttm)

2.34

Revenue per share (ttm)

2.34

Quarterly revenue growth (yoy)

Gross profit (ttm)

42.36M

EBITDA

-57,918,000.00

Net income to common (ttm)

-57,321,000.00

Diluted EPS (ttm)

-2.23

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

44.40M

Total cash per share (mrq)

1.69

Total debt (mrq)

45.63M

Total Debt/Equity (mrq)

373.16

Current ratio (mrq)

372.90%

Book value per share (mrq)

0.47

Cash flow

Cash flow statement

-51,721,000.00

Levered free cash flow (LFCF)

-33,676,376.00